Ontario Genomics

Three OG seeded companies get additional funding

August 17, 2015

InDanio Bioscience, Encycle Therapeautics made new research partnerships for research and drug development and RNA Diagnostics received angel investment.

Two SMEs, InDanio Bioscience and Encycle Therapeautics will partner with Toronto researchers and provide in-kind contributions to the $1.5M funding by CQDM and CIHR, through its institutes of Cancer Research, Genetics and Infection and Immunity medicine, for two translational projects in personalized medicine to accelerate drug discovery and drug development. In addition, RNA Diagnostics, a Sudbury-based medical diagnostic company, has successfully closed an additional round of angel investment with support of the NORCAT Innovation Mill Angel group. The Ontario Genomics Institute’s Pre-commercialization Business Development Fund (PBDF) funded RNA Diagnostics in 2012, InDanio Bioscience in 2010.